Opinion statement
Newly acquired neuromuscular weakness commonly develops in the setting of critical illness. This weakness delays recovery and often causes prolonged ventilator dependence. An axonal sensory-motor polyneuropathy, critical illness polyneuropathy (CIP), is seen in up to a third of critically ill patients with the systemic inflammatory response syndrome (usually due to sepsis). As frequently, or more so, an acute myopathy, critical illness myopathy (CIM), develops in a similar setting, often in association with the use of corticosteroids and/or nondepolarizing neuromuscular-blocking agents. This paper reviews the clinical features, diagnostic approach, and treatment of CIP and CIM. There are no specific pharmacologic treatments for CIP or CIM, but recognizing the presence of one of these disorders often improves management. Prevention of CIP and CIM is feasible in part by avoiding risk factors and by aggressive medical management of critically ill patients. Intensive insulin therapy in intensive care unit patients appears to reduce the likelihood of developing CIP and/or CIM. Future treatments of sepsis may further reduce the incidence of these neuromuscular consequences of critical illness.
Article PDF
Similar content being viewed by others
References and Recommended Reading
Witt NJ, Zochodne DW, Bolton CF, et al.: Peripheral nerve function in sepsis and multiple organ failure. Chest 1991, 99:176–184.
Leijten FS, Harinck-de Weerd JE, Poortvleit DC, de Weerd AW: The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 1995, 274:1221–1225.
Lacomis D, Petrella JT, Giuliani MJ: Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients. Muscle Nerve 1998, 21:610–617.
De Letter MC, Schmitz PI, Visser LH, et al.: Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 2001, 29:2281–2286.
De Jonghe B, Sharshar T, Lefaucher JP, et al.: Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002, 288:2859–2867.
Bednarik J, Vondracek P, Dusek L, et al.: Risk factors for critical illness polyneuromyopathy. J Neurol 2005, 252:343–351.
Bolton CF: Electrophysiologic studies of critically ill patients. Muscle Nerve 1987, 10:129–135.
Bolton CF, Young GB, Zochodne DW: The neurologic complications of sepsis. Ann Neurol 1993, 33:94–100.
Zochodne DW, Bolton CF, Wells GA, et al.: Critical illness polyneuropathy. Brain 1987, 110:819–842.
Zifko U, Zipko H, Bolton CF: Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci 1998, 159:186–198.
Bird SJ, Rich MM: Critical illness myopathy and polyneuropathy. Curr Neurol Neurosci Rep 2002, 2:527–533.
Bolton CF: Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996, 24:1408–1416.
Op de Coul AAW, Lambregts PC, Koeman J, et al.: Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation. Clin Neurol Neurosurg 1985, 87:17–22.
Hirano M, Ott BR, Raps EC, et al.: Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 1992, 42:2082–2087.
Hanson P, Dive A, Brucher JM, et al.: Acute corticosteroid myopathy in intensive care patients. Muscle Nerve 1997, 20:1371–1380.
Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ: Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 1996, 40:645–654.
Rich MM, Teener JW, Raps EC, et al.: Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 1996, 46:731–736.
Rich MM, Bird SJ, Raps EC, et al.: Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 1997, 20:665–673.
Trojaborg W, Weimer LH, Hays AP: Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy—a reappraisal. Clin Neurophysiol 2001, 112:1586–1593.
Bednarik J, Lukas Z, Vondracek P: Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med 2003, 29:1505–1514.
Lefaucher JP, Nordine T, Rodriguez P, Brouchard L: Origin of ICU acquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatry 2006, 77:500–506.
Danon MJ, Carpenter S: Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991, 14:1131–1139.
Teener JW, Rich MM: Dysregulation of sodium channel gating in critical illness myopathy. J Muscle Res Cell Motil 2006, 27:291–296.
Berek K, Margreiter J, Willeit J: Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med 1993, 22:849–855.
Leijten FSS, Harinck-De Weerd JE, Poortvliet DCJ, De Weerd AW: Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med 1996, 22:856–861.
Lacomis D, Zochodne DW, Bird SJ: Critical illness myopathy: what’s in a name? Muscle Nerve 2000, 23:1767–1772.
Campellone JV, Lacomis D, Kramer DJ, et al.: Acute myopathy after liver transplantation. Neurology 1998, 50:46–53.
Hanson P, Dive A, Brucher JM, et al.: Acute corticosteroid myopathy in intensive care patients. Muscle Nerve 1997, 20:1371–1380.
De Jonghe B, Bastuji-Garin S, Sharshar T, et al.: Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med 2004, 30:1117–1121.
Garnacho-Montero J, Amaya-Villar R, Garcia-Garmendia JL, et al.: Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med 2005, 33:349–354.
David WS, Roehr CL, Leatherman JW: EMG findings in acute myopathy with status asthmaticus, steroids, and paralytics: clinical and electrophysiologic correlation. Electromyogr Clin Neurophysiol 1998, 38:371–376.
Bolton CF: Neuromuscular manifestations of critical illness. Muscle Nerve 2005, 32:140–163.
Latronico N, Shehu I, Seghelini E: Neuromuscular sequelae of critical illness. Curr Opin Crit Care 2005, 11:381–390.
Fletcher SN, Kennedy DD, Ghosh IR, et al.: Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 2003, 31:1012–1016.
Hansen-Flaschen JH, Cowen J, Raps EC: Neuromuscular blockade in the intensive care unit: more than we bargained for. Am Rev Respir Dis 1993, 147:234–236.
Sladen RN: Neuromuscular blocking agents in the intensive care unit: a two-edged sword. Crit Care Med 1995, 23:423–428.
Murray MJ, Cowen J, DeBlock H, et al.: Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002, 30:142–156.
National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network: Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006, 354:1671–1684.
Wijdicks EF, Fulgham JR: Failure of high dose intravenous immunoglobulins to alter the clinical course of critical illness polyneuropathy. Muscle Nerve 1994, 17:1494–1495.
Mohr M, Englisch L, Roth A, et al.: Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med 1997, 23:1144–1149.
Van den Berghe G, Wouters P, Weekers F, et al.: Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345:1359–1367.
Van den Berghe G, Schoonheydt K, Becx P, et al.: Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005, 64:1348–1353.
Van der Schaaf M, Beelen A, De Vos R: Functional outcome in patients with critical illness polyneuropathy. Disabil Rehabil 2004, 26:1189–1197.
Novak F, Heyland DK, Avenell A, et al.: Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002, 30:2022–2029.
Friedrich O: Critical illness myopathy: what is happening? Curr Opin Clin Nutr Metab Care 2006, 9:403–409.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bird, S.J. Diagnosis and management of critical illness polyneuropathy and critical illness myopathy. Curr Treat Options Neurol 9, 85–92 (2007). https://doi.org/10.1007/s11940-007-0034-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11940-007-0034-1